BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22714978)

  • 1. Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus.
    Valente T; Gella A; Solé M; Durany N; Unzeta M
    J Neurosci Res; 2012 Oct; 90(10):1989-96. PubMed ID: 22714978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
    Solé M; Miñano-Molina AJ; Unzeta M
    Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats.
    Somfai GM; Knippel B; Ruzicska E; Stadler K; Tóth M; Salacz G; Magyar K; Somogyi A
    Neurochem Int; 2006 Jun; 48(8):746-52. PubMed ID: 16524643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
    Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
    Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Ferrer I; Lizcano JM; Hernández M; Unzeta M
    Neurosci Lett; 2002 Mar; 321(1-2):21-4. PubMed ID: 11872247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
    Jiang ZJ; Richardson JS; Yu PH
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
    Solé M; Unzeta M
    Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
    Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
    Yu PH
    Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.
    Unzeta M; Solé M; Boada M; Hernández M
    J Neural Transm (Vienna); 2007; 114(6):857-62. PubMed ID: 17393059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging.
    del Mar Hernandez M; Esteban M; Szabo P; Boada M; Unzeta M
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):183-7. PubMed ID: 15894424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
    Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
    Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
    Sun P; Esteban G; Inokuchi T; Marco-Contelles J; Weksler BB; Romero IA; Couraud PO; Unzeta M; Solé M
    Br J Pharmacol; 2015 Nov; 172(22):5390-402. PubMed ID: 26362823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
    Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular adhesion protein-1 in human ischaemic stroke.
    Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
    Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
    Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
    Abella A; García-Vicente S; Viguerie N; Ros-Baró A; Camps M; Palacín M; Zorzano A; Marti L
    Diabetologia; 2004 Mar; 47(3):429-438. PubMed ID: 14968297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.